Effects of Acute and One-Week Supplementation with Montmorency Tart Cherry Powder on Food-Induced Uremic Response and Markers of Health: A Proof-of-Concept Study
Nutrients · 2024
DOI: 10.3390/nu16193391 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2024. Verfasst von Drew E Gonzalez und 12 weiteren Autor:innen. Beteiligte Einrichtung: Exercise & Sport Nutrition Lab, Department of Kinesiology and Sports Management, Texas A&M University, College Station, TX 77843, USA. Hauptthemen laut MEDLINE: Cross-Over Studies, Uric Acid, Biomarkers, Dietary Supplements. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Anderson Advanced Ingredients, Anderson Advanced Ingredients (Irvine, CA), in collaboration with Shoreline Fruit LLC (Traverse, MI).
Abstract (Originalsprache)
Metabolic conditions, such as gout, can result from elevated uric acid (UA) levels. Consuming high-purine meals increases UA levels. Therefore, people with hyperuricemia typically must avoid ingesting such foods. Polyphenols have been shown to reduce uric acid levels and tart cherries (TCs) are a rich source of phenolic and anthocyanin compounds. This proof-of-concept study evaluated whether ingesting TCs with a purine-rich meal affects the uricemic response.
Methods
A total of 25 adults (15 males and 10 females, 85.0 ± 17 kg, 40.6 ± 9 years, 29.1 ± 4.9 kg/m2) with elevated fasting UA levels (5.8 ± 1.3 mg/dL) donated a fasting blood sample. In a randomized, double-blind, crossover, placebo-controlled, counterbalanced manner, participants ingested capsules containing 960 mg of a placebo (PLA) or concentrated TC powder containing 20.7 mg of proanthocyanins with a serving of hot soup (10 g of carbohydrate, 2 g protein, and 1 g fat) containing 3 g of purines (1 g of adenosine 5′-monophosphate, 1 g of disodium 5′-guanylate, and 1 g of disodium 5′-inosinate). Blood samples were obtained at 0, 60, 120, 180, and 240 min after ingestion to assess changes in uric acid levels and pharmacokinetic profiles. Cell blood counts, a comprehensive metabolic panel, cytokines, inflammatory markers, and subjective side effects ratings were analyzed on baseline (0 min) and post-treatment (240 min) samples. Participants continued consuming two capsules/day of the assigned treatment for one week and then repeated the experiment. Participants observed a 14-day washout and then repeated the experiment while ingesting the alternate treatment. Data were analyzed using general linear model (GLM) statistics with repeated measures, pairwise comparisons, and percentage change from baseline with 95% confidence intervals (CIs).
Results
No statistically significant interaction effects or differences between treatments were seen in uric acid levels or PK profiles. Analysis of percent changes from baseline revealed that TC ingestion reduced the blood glucose levels following the ingestion of the high-purine meal (−4.2% [−7.7, −0.7], p = 0017). Additionally, there was some evidence that TC ingestion attenuated the increase from baseline in IL-1β and IL-10 and increased INF-γ. No significant differences were seen in the remaining health markers or subjective side effects ratings.
Conclusions
Acute and one-week TC supplementation did not affect the uricemic response to ingesting a high-purine meal in individuals with mildly elevated UA levels. However, there was some evidence that TC supplementation may blunt the glycemic response to ingesting a meal and influence some inflammatory cytokines. Registered clinical trial NCT04837274.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Exercise & Sport Nutrition Lab, Department of Kinesiology and Sports Management, Texas A&M University, College Station, TX 77843, USA.
ORCID-Profile: Drew E Gonzalez, Jacob A Kendra, Broderick L Dickerson, Victoria Martinez, Megan Leonard, Ryan J Sowinski, Richard B Kreider
Förderung
- Anderson Advanced Ingredients
- Anderson Advanced Ingredients (Irvine, CA), in collaboration with Shoreline Fruit LLC (Traverse, MI)
Zitieren
APA
Gonzalez, D. E., Kendra, J. A., Dickerson, B. L., Yoo, C., Ko, J., McAngus, K., Martinez, V., Leonard, M., Johnson, S. E., Xing, D., Sowinski, R. J., Rasmussen, C. J., & Kreider, R. B. (2024). Effects of Acute and One-Week Supplementation with Montmorency Tart Cherry Powder on Food-Induced Uremic Response and Markers of Health: A Proof-of-Concept Study. Nutrients. https://doi.org/10.3390/nu16193391
Vancouver
Gonzalez DE, Kendra JA, Dickerson BL, Yoo C, Ko J, McAngus K, et al. Effects of Acute and One-Week Supplementation with Montmorency Tart Cherry Powder on Food-Induced Uremic Response and Markers of Health: A Proof-of-Concept Study. Nutrients. 2024. doi:10.3390/nu16193391
BibTeX
@article{Gonzalez2024,
author = {Gonzalez, Drew E and Kendra, Jacob A and Dickerson, Broderick L and Yoo, Choongsung and Ko, Joungbo and McAngus, Kay and Martinez, Victoria and Leonard, Megan and Johnson, Sarah E and Xing, Dante and Sowinski, Ryan J and Rasmussen, Christopher J and Kreider, Richard B},
title = {Effects of Acute and One-Week Supplementation with Montmorency Tart Cherry Powder on Food-Induced Uremic Response and Markers of Health: A Proof-of-Concept Study},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16193391}
}
EUVIMED